Niti Goel, M.D., is a board-certified rheumatologist and physician-scientist with over 25 years of industry experience who discerns the clinical and market potential of new molecules and products, focused on getting them approved, prescribed, and in the hands of the people who need them. She currently serves as a clinical consultant to Centrexion and is President of Caduceus Biomedical Consulting. She has held senior leadership roles at TrialSpark (now Formation Bio), Abcuro, Kezar Life Sciences, and IQVIA, as well as various roles at Array BioPharma, Inc., UCB Pharma, and Procter & Gamble Pharmaceuticals. She is also currently an Adjunct Assistant Professor at Duke University School of Medicine, precepting trainees in the rheumatology clinic at the Durham Veterans Administration Hospital. Niti has interests in novel trial design; representativeness in clinical trials; inclusion of the patient perspective in clinical research endeavors; and mentoring individuals at all career levels. She graduated summa cum laude with her M.D. degree from Jefferson Medical College of Thomas Jefferson University and completed her internal medicine and rheumatology training at Duke University Medical Center.